Curative therapy of a hepatitis C infection due to an infected heart donor: 5-year outcomes after heart transplantation

Khalil Jawad; Stefan Feder; Markus Barten; Jens Garbade

doi:10.1093/ejcts/ezy051

Curative therapy of a hepatitis C infection due to an infected heart donor: 5-year outcomes after heart transplantation

Khalil Jawad
Stefan Feder
Markus Barten
Jens Garbade

Related Research units

Department for Cardiovascular Surgery

Abstract

Heart transplantation is the gold standard therapy for patients diagnosed with end-stage heart failure. Despite the shortage of appropriate donor organs, the transplantation of hepatitis C-infected hearts is disputed. Previous research has shown that long-term results are controversial, and the risk of severe clinical infection should not be underestimated.

Bibliographical data

Original language	English
ISSN	1010-7940
DOIs	https://doi.org/10.1093/ejcts/ezy051
Publication status	Published - 01.08.2018

Comment Deanary

Editorial Material

PubMed	29514173